Instrument/analyser IVDs

国: オーストラリア

言語: 英語

ソース: Department of Health (Therapeutic Goods Administration)

即購入

ダウンロード 公開評価報告書 (PAR)
29-05-2020

から入手可能:

Martin Flynn PTY LTD

クラス:

Class 1

製:

DRG International Inc 841 Mountain Avenue, Springfield, NJ, 07081 United States Of America

治療領域:

CT943 - Instrument/analyser IVDs

適応症:

HYB-5252 -GMDN 56718/62413 - The DRG:HYBRiD-XL? was developed for the use in Laboratories, Institutions and Doctors Practices. The DRG:HYBRID-XL? is capable of processing a broad variety of Clinical Chemistry and immunoassay. The DRG:HYBRiD-XL? is a random-access analyzer intended for professional use and must only be used by trained personnel working in compliance with the precautions for use set out in this manual and good laboratory practice (GLP).

認証ステータス:

A

承認日:

2020-02-13

この製品に関連するアラートを検索

ドキュメントの履歴を表示する